Department of Thoracic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Department of Immunology, Tokyo Medical University, Tokyo, Japan.
Adv Exp Med Biol. 2024;1444:197-205. doi: 10.1007/978-981-99-9781-7_13.
Programmed cell death-1 (PD-1) is one of the most famous coinhibitory receptors that are expressed on effector T cells to regulate their function. The PD-1 ligands, PD-L1 and PD-L2, are expressed by various cells throughout the body at steady state and their expression was further regulated within different pathological conditions such as tumor-bearing and chronic inflammatory diseases. In recent years, immune checkpoint inhibitor (ICI) therapies with anti-PD-1 or anti-PD-L1 has become a standard treatment for various malignancies and has shown remarkable antitumor effects. Since the discovery of PD-1 in 1992, a huge number of studies have been conducted to elucidate the function of PD-1. Herein, this paper provides an overview of PD-1 biological findings and sheds some light on the current technology for molecular imaging of PD-1.
程序性细胞死亡受体 1(PD-1)是表达在效应 T 细胞上的最著名的共抑制受体之一,用于调节其功能。PD-1 的配体 PD-L1 和 PD-L2 在静息状态下由体内各种细胞表达,其表达在肿瘤和慢性炎症等不同病理条件下进一步受到调节。近年来,抗 PD-1 或抗 PD-L1 的免疫检查点抑制剂(ICI)疗法已成为各种恶性肿瘤的标准治疗方法,并显示出显著的抗肿瘤作用。自 1992 年 PD-1 被发现以来,已经进行了大量研究来阐明 PD-1 的功能。本文综述了 PD-1 的生物学发现,并对 PD-1 分子成像的当前技术进行了探讨。